scispace - formally typeset
Search or ask a question
Institution

American Cancer Society

NonprofitAtlanta, Georgia, United States
About: American Cancer Society is a nonprofit organization based out in Atlanta, Georgia, United States. It is known for research contribution in the topics: Cancer & Population. The organization has 1339 authors who have published 3700 publications receiving 688166 citations. The organization is also known as: American Cancer Society, ACS & American Society for the Control of Cancer.


Papers
More filters
Journal ArticleDOI
Xifeng Wu, Ghislaine Scelo1, Mark P. Purdue, Nathaniel Rothman, Mattias Johansson1, Yuanqing Ye, Zhaoming Wang2, Diana Zelenika3, Lee E. Moore, Christopher G. Wood4, Egor Prokhortchouk5, Valerie Gaborieau1, Kevin B. Jacobs2, Wong-Ho Chow, Jorge R. Toro, David Zaridze, Jie Lin, Jan Lubinski6, Joanna Trubicka6, Neonilia Szeszenia-Dabrowska, Jolanta Lissowska, Peter Rudnai7, Eleonora Fabianova, Dana Mates, Viorel Jinga, Vladimir Bencko8, Alena Slamova8, Ivana Holcatova8, Marie Navratilova, Vladimir Janout9, Paolo Boffetta10, Joanne S. Colt, Faith G. Davis11, Kendra Schwartz12, Rosamonde E. Banks, Peter Selby, Patricia Harnden13, Christine D. Berg7, Ann W. Hsing, Robert L. Grubb14, Heiner Boeing, Paolo Vineis14, Paolo Vineis15, Françoise Clavel-Chapelon16, Françoise Clavel-Chapelon17, Domenico Palli18, Rosario Tumino, Vittorio Krogh, Salvatore Panico, Eric J. Duell, José Ramón Quirós, María José Sánchez19, Carmen Navarro, Eva Ardanaz, Miren Dorronsoro, Kay-Tee Khaw20, Naomi E. Allen21, H. Bas Bueno-de-Mesquita, Petra H.M. Peeters22, Dimitrios Trichopoulos23, Dimitrios Trichopoulos24, Jakob Linseisen25, Börje Ljungberg26, Kim Overvad27, Anne Tjønneland, Isabelle Romieu1, Elio Riboli, Victoria L. Stevens28, Michael J. Thun28, W. Ryan Diver28, Susan M. Gapstur28, Paul D.P. Pharoah20, Douglas F. Easton20, Demetrius Albanes, Jarmo Virtamo7, Lars J. Vatten29, Kristian Hveem29, Tony Fletcher30, Kvetoslava Koppova, Olivier Cussenot, Geraldine Cancel-Tassin, Simone Benhamou16, Simone Benhamou31, Michelle A.T. Hildebrandt, Xia Pu, Mario Foglio3, Doris Lechner3, Amy Hutchinson2, Meredith Yeager2, Joseph F. Fraumeni, Mark Lathrop3, Konstantin G. Skryabin, James McKay1, Jian Gu, Paul Brennan1, Stephen J. Chanock 
TL;DR: To the knowledge, this is the first genetic locus associated with both cancer risk and WHR, and the top 500 SNPs in silico in 3772 cases and 8505 controls of European descent involved in the only published genome-wide association study of RCC are analyzed.
Abstract: Renal cell carcinoma (RCC) is the most lethal urologic cancer. Only two common susceptibility loci for RCC have been confirmed to date. To identify additional RCC common susceptibility loci, we conducted an independent genome- wide association study (GWAS). We analyzed 533 191 single nucleotide polymorphisms (SNPs) for association with RCC in 894 cases and 1516 controls of European descent recruited from MD Anderson Cancer Center in the primary scan, and validated the top 500 SNPs in silico in 3772 cases and 8505 controls of European descent involved in the only published GWAS of RCC. We identified two common variants in linkage disequilibrium, rs718314 and rs1049380 (r(2) = 0.64, D' = 0.84), in the inositol 1,4,5-triphosphate receptor, type 2 (ITPR2) gene on 12p11.23 as novel susceptibility loci for RCC (P = 8.89 x 10(-10) and P = 6.07 x 10(-9), respectively, in meta-analysis) with an allelic odds ratio of 1.19 [95% confidence interval (CI): 1.13-1.26] for rs718314 and 1.18 (95% CI: 1.12-1.25) for rs1049380. It has been recently identified that rs718314 in ITPR2 is associated with waist-hip ratio (WHR) phenotype. To our knowledge, this is the first genetic locus associated with both cancer risk and WHR.

90 citations

Journal ArticleDOI
TL;DR: A multilevel, multidimensional conceptual framework is presented for transdisciplinary research teams to use to think together about the influence of culture on tobacco and of tobacco on culture and challenges researchers to think about how the sociocultural context influences tobacco use at micro, meso, and macro levels.
Abstract: Understanding culture is an essential key to reducing tobacco use. Conceptualizations of culture vary across scientific disciplines and theoretical orientations. Because of the complexity of the causes and effects of tobacco use, no single discipline has sufficient capacity to undertake a comprehensive approach to studying culture and tobacco. Transdisciplinary research offers a means of bridging disciplinary perspectives. This paper reviews epidemiological data on observed variation in smoking patterns across national groups, ethnicities and genders, and presents reasons for studying culture in tobacco control research. We discuss and contrast conceptualizations and specific definitions of culture and identify aspects of each conceptualization that are relevant to research on tobacco. We present a multilevel, multidimensional conceptual framework for transdisciplinary research teams to use to think together about the influence of culture on tobacco and of tobacco on culture. The framework challenges researchers to think about how the sociocultural context influences tobacco use at micro, meso, and macro levels. Finally, we offer suggestions for improving transdisciplinary research on culture and tobacco.

90 citations

Journal ArticleDOI
01 Jan 2009-Cancer
TL;DR: A national assessment of prevalence and trends of indoor tanning use among US adolescents is provided to examine changes in the prevalence of indoorTanning use from 1998 to 2004 in relation to state policies on minors' access, and to assessThe prevalence of burns, rashes, and infections among users.
Abstract: BACKGROUND: A recent meta-analysis found that indoor tanning use before the age of 35 years increases the risk of melanoma, supporting policies to restrict indoor tanning use among adolescents The objectives of the current study were to provide a national assessment of prevalence and trends of indoor tanning use among US adolescents, to examine changes in the prevalence of indoor tanning use from 1998 to 2004 in relation to state policies on minors' access, and to assess the prevalence of burns, rashes, and infections among users METHODS: Two cross-sectional population-based surveys of US youths ages 11 to 18 years and their parents/guardians conducted in 1998 (N = 1196) and 2004 (N = 1613) used identical questions to assess use of indoor tanning and correlates of this behavior RESULTS: The prevalence of indoor tanning use by adolescents within the past year changed little from 1998 to 2004 (10% to 11%) In states with policies regarding minors' access to indoor tanning, the prevalence stayed the same or decreased from 1998 to 2004, whereas it increased in states without such policies Neither trend was found to be statistically significant Youth tanning attitudes, parental indoor tanning use, and parents' permission were strongly associated with youth use of indoor tanning Fifty-eight percent of users reported burns from indoor tanning CONCLUSIONS: The presence of state legislation restricting minors' access to indoor tanning appears to have limited effectiveness, perhaps because most states' policies permit use with parental consent Multipronged approaches are needed to reduce indoor tanning use in youths Cancer 2009 Published 2008 by the American Cancer Society

89 citations

Journal ArticleDOI
TL;DR: It is suggested that a common haplotype in the TLR10‐TLR1‐TLr6 gene cluster influences prostate cancer risk and clearly supports the need for further investigation of TLR genes in other populations.
Abstract: Toll-like receptors (TLRs) are key players in the innate immune system and initiate the inflammatory response to foreign pathogens such as bacteria, fungi and viruses. The proposed role of chronic inflammation in prostate carcinogenesis has prompted investigation into the association of common genetic variation in TLRs with the risk of this cancer. We investigated the role of common SNPs in a gene cluster encoding the TLR10, TLR6 and TLR1 proteins in prostate cancer etiology among 1,414 cancer cases and 1,414 matched controls from the Cancer Prevention Study II Nutrition Cohort. Twenty-eight SNPs, which included the majority of the common nonsynonymous SNPs in the 54-kb gene region and haplotype-tagging SNPs that defined 5 specific haplotype blocks, were genotyped and their association with prostate cancer risk determined. Two SNPs in TLR10 [I369L (rs11096955) and N241H (rs11096957)] and 4 SNPs in TLR1 [N248S (rs4833095), S26L (rs5743596), rs5743595 and rs5743551] were associated with a statistically significant reduced risk of prostate cancer of 29-38% (for the homozygous variant genotype). The association of these SNPs was similar when the analysis was limited to cases with advanced prostate cancer. Haplotype analysis and linkage disequilibrium findings revealed that the 6 associated SNPs were not independent and represent a single association with reduced prostate cancer risk (OR = 0.55, 95% CI: 0.33, 0.90). Our study suggest that a common haplotype in the TLR10-TLR1-TLR6 gene cluster influences prostate cancer risk and clearly supports the need for further investigation of TLR genes in other populations.

89 citations

Journal ArticleDOI
18 May 2021-JAMA
TL;DR: In this article, the authors compared three microsimulation models of colorectal cancer screening in a hypothetical cohort of 40-year-old US individuals at average risk of colon cancer and identified strategies that may provide an efficient balance of life-years gained (LYG) from screening and colonoscopy burden.
Abstract: Importance The US Preventive Services Task Force (USPSTF) is updating its 2016 colorectal cancer screening recommendations. Objective To provide updated model-based estimates of the benefits, burden, and harms of colorectal cancer screening strategies and to identify strategies that may provide an efficient balance of life-years gained (LYG) from screening and colonoscopy burden to inform the USPSTF. Design, setting, and participants Comparative modeling study using 3 microsimulation models of colorectal cancer screening in a hypothetical cohort of 40-year-old US individuals at average risk of colorectal cancer. Exposures Screening from ages 45, 50, or 55 years to ages 70, 75, 80, or 85 years with fecal immunochemical testing (FIT), multitarget stool DNA testing, flexible sigmoidoscopy alone or with FIT, computed tomography colonography, or colonoscopy. All persons with an abnormal noncolonoscopy screening test result were assumed to undergo follow-up colonoscopy. Screening intervals varied by test. Full adherence with all procedures was assumed. Main outcome and measures Estimated LYG relative to no screening (benefit), lifetime number of colonoscopies (burden), number of complications from screening (harms), and balance of incremental burden and benefit (efficiency ratios). Efficient strategies were those estimated to require fewer additional colonoscopies per additional LYG relative to other strategies. Results Estimated LYG from screening strategies ranged from 171 to 381 per 1000 40-year-olds. Lifetime colonoscopy burden ranged from 624 to 6817 per 1000 individuals, and screening complications ranged from 5 to 22 per 1000 individuals. Among the 49 strategies that were efficient options with all 3 models, 41 specified screening beginning at age 45. No single age to end screening was predominant among the efficient strategies, although the additional LYG from continuing screening after age 75 were generally small. With the exception of a 5-year interval for computed tomography colonography, no screening interval predominated among the efficient strategies for each modality. Among the strategies highlighted in the 2016 USPSTF recommendation, lowering the age to begin screening from 50 to 45 years was estimated to result in 22 to 27 additional LYG, 161 to 784 additional colonoscopies, and 0.1 to 2 additional complications per 1000 persons (ranges are across screening strategies, based on mean estimates across models). Assuming full adherence, screening outcomes and efficient strategies were similar by sex and race and across 3 scenarios for population risk of colorectal cancer. Conclusions and relevance This microsimulation modeling analysis suggests that screening for colorectal cancer with stool tests, endoscopic tests, or computed tomography colonography starting at age 45 years provides an efficient balance of colonoscopy burden and life-years gained.

89 citations


Authors

Showing all 1345 results

NameH-indexPapersCitations
Walter C. Willett3342399413322
Meir J. Stampfer2771414283776
Frank B. Hu2501675253464
David J. Hunter2131836207050
Edward Giovannucci2061671179875
Irving L. Weissman2011141172504
Bernard Rosner1901162147661
Susan E. Hankinson15178988297
Paolo Boffetta148145593876
Jeffrey A. Bluestone14351577080
Richard D. Smith140118079758
Garth D. Illingworth13750561793
Brian E. Henderson13771269921
Ahmedin Jemal132500380474
Michael J. Thun12939279051
Network Information
Related Institutions (5)
University of Texas MD Anderson Cancer Center
92.5K papers, 4.7M citations

89% related

Memorial Sloan Kettering Cancer Center
65.3K papers, 4.4M citations

89% related

Fred Hutchinson Cancer Research Center
30.9K papers, 2.2M citations

88% related

Mayo Clinic
169.5K papers, 8.1M citations

86% related

University of California, San Francisco
186.2K papers, 12M citations

85% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202312
20228
2021202
2020239
2019222
2018194